Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Gross Margin (2025)

Coeptis Therapeutics Holdings has reported Gross Margin over the past 1 years, most recently at 94.76% for Q4 2025.

  • Quarterly results put Gross Margin at 94.76% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 86.75% (changed N/A YoY), and the annual figure for FY2025 was 86.75%, changed.
  • Gross Margin for Q4 2025 was 94.76% at Coeptis Therapeutics Holdings, up from 80.98% in the prior quarter.
  • Over the last five years, Gross Margin for COEPW hit a ceiling of 94.76% in Q4 2025 and a floor of 28.18% in Q1 2025.